57 related articles for article (PubMed ID: 21647864)
1. Therapeutic approaches in the treatment of juvenile dermatomyositis in patients with recent-onset disease and in those experiencing disease flare: an international multicenter PRINTO study.
Hasija R; Pistorio A; Ravelli A; Demirkaya E; Khubchandani R; Guseinova D; Malattia C; Canhao H; Harel L; Foell D; Wouters C; De Cunto C; Huemer C; Kimura Y; Mangge H; Minetti C; Nordal EB; Philippet P; Garozzo R; Martini A; Ruperto N;
Arthritis Rheum; 2011 Oct; 63(10):3142-52. PubMed ID: 21647864
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling.
Deakin CT; Campanilho-Marques R; Simou S; Moraitis E; Wedderburn LR; Pullenayegum E; Pilkington CA;
Arthritis Rheumatol; 2018 May; 70(5):785-793. PubMed ID: 29342499
[TBL] [Abstract][Full Text] [Related]
3. The role of aggressive corticosteroid therapy in patients with juvenile dermatomyositis: a propensity score analysis.
Seshadri R; Feldman BM; Ilowite N; Cawkwell G; Pachman LM
Arthritis Rheum; 2008 Jul; 59(7):989-95. PubMed ID: 18576304
[TBL] [Abstract][Full Text] [Related]
4. Juvenile Dermatomyositis Early Onset, Case Report.
Boyvadoglu C; Kartal D
Indian Dermatol Online J; 2024; 15(3):507-508. PubMed ID: 38845637
[No Abstract] [Full Text] [Related]
5. Baseline characteristics of children with juvenile dermatomyositis enrolled in the first year of the new Childhood Arthritis and Rheumatology Research Alliance registry.
Neely J; Ardalan K; Huber A; Kim S;
Pediatr Rheumatol Online J; 2022 Jul; 20(1):50. PubMed ID: 35854378
[TBL] [Abstract][Full Text] [Related]
6. Juvenile Dermatomyositis Magnetic Resonance Imaging Score (JIS) does not correlate with criteria for clinically inactive disease: a single-centre retrospective evaluation.
Gargh K; Al-Abadi E; Low S; Harrison K; Coles W; Davis P; Johnson K
Rheumatol Int; 2022 Jul; 42(7):1221-1226. PubMed ID: 34796407
[TBL] [Abstract][Full Text] [Related]
7. The PRINTO evidence-based proposal for glucocorticoids tapering/discontinuation in new onset juvenile dermatomyositis patients.
Giancane G; Lavarello C; Pistorio A; Oliveira SK; Zulian F; Cuttica R; Fischbach M; Magnusson B; Pastore S; Marini R; Martino S; Pagnier A; Soler C; Staņēvicha V; Ten Cate R; Uziel Y; Vojinovic J; Fueri E; Ravelli A; Martini A; Ruperto N;
Pediatr Rheumatol Online J; 2019 May; 17(1):24. PubMed ID: 31118099
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of autologous hematopoietic stem cell transplantation for refractory juvenile dermatomyositis: a case-series study.
Zhu J; Su G; Lai J; Dong B; Kang M; Li S; Zhou Z; Wu F
Pediatr Rheumatol Online J; 2018 Nov; 16(1):72. PubMed ID: 30458860
[TBL] [Abstract][Full Text] [Related]
9. Current management of juvenile dermatomyositis in Germany and Austria: an online survey of pediatric rheumatologists and pediatric neurologists.
Hinze CH; Speth F; Oommen PT; Haas JP
Pediatr Rheumatol Online J; 2018 Jun; 16(1):38. PubMed ID: 29925381
[TBL] [Abstract][Full Text] [Related]
10. Medications received by patients with juvenile dermatomyositis.
Kishi T; Bayat N; Ward MM; Huber AM; Wu L; Mamyrova G; Targoff IN; Warren-Hicks WJ; Miller FW; Rider LG;
Semin Arthritis Rheum; 2018 Dec; 48(3):513-522. PubMed ID: 29773230
[TBL] [Abstract][Full Text] [Related]
11. Update on outcome assessment in myositis.
Rider LG; Aggarwal R; Machado PM; Hogrel JY; Reed AM; Christopher-Stine L; Ruperto N
Nat Rev Rheumatol; 2018 May; 14(5):303-318. PubMed ID: 29651119
[TBL] [Abstract][Full Text] [Related]
12. Innovative Research Design to Meet the Challenges of Clinical Trials for Juvenile Dermatomyositis.
Rosina S; Varnier GC; Mazzoni M; Lanni S; Malattia C; Ravelli A
Curr Rheumatol Rep; 2018 Apr; 20(5):29. PubMed ID: 29637406
[TBL] [Abstract][Full Text] [Related]
13. 2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspects.
Rider LG; Ruperto N; Pistorio A; Erman B; Bayat N; Lachenbruch PA; Rockette H; Feldman BM; Huber AM; Hansen P; Oddis CV; Lundberg IE; Amato AA; Chinoy H; Cooper RG; Chung L; Danko K; Fiorentino D; García-De la Torre I; Reed AM; Wook Song Y; Cimaz R; Cuttica RJ; Pilkington CA; Martini A; van der Net J; Maillard S; Miller FW; Vencovsky J; Aggarwal R;
Rheumatology (Oxford); 2017 Nov; 56(11):1884-1893. PubMed ID: 28977549
[TBL] [Abstract][Full Text] [Related]
14. Environmental factors associated with disease flare in juvenile and adult dermatomyositis.
Mamyrova G; Rider LG; Ehrlich A; Jones O; Pachman LM; Nickeson R; Criscone-Schreiber LG; Jung LK; Miller FW; Katz JD
Rheumatology (Oxford); 2017 Aug; 56(8):1342-1347. PubMed ID: 28444299
[TBL] [Abstract][Full Text] [Related]
15. 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.
Rider LG; Aggarwal R; Pistorio A; Bayat N; Erman B; Feldman BM; Huber AM; Cimaz R; Cuttica RJ; de Oliveira SK; Lindsley CB; Pilkington CA; Punaro M; Ravelli A; Reed AM; Rouster-Stevens K; van Royen-Kerkhof A; Dressler F; Saad Magalhaes C; Constantin T; Davidson JE; Magnusson B; Russo R; Villa L; Rinaldi M; Rockette H; Lachenbruch PA; Miller FW; Vencovsky J; Ruperto N;
Ann Rheum Dis; 2017 May; 76(5):782-791. PubMed ID: 28385804
[TBL] [Abstract][Full Text] [Related]
16. 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.
Aggarwal R; Rider LG; Ruperto N; Bayat N; Erman B; Feldman BM; Oddis CV; Amato AA; Chinoy H; Cooper RG; Dastmalchi M; Fiorentino D; Isenberg D; Katz JD; Mammen A; de Visser M; Ytterberg SR; Lundberg IE; Chung L; Danko K; García-De la Torre I; Song YW; Villa L; Rinaldi M; Rockette H; Lachenbruch PA; Miller FW; Vencovsky J;
Arthritis Rheumatol; 2017 May; 69(5):898-910. PubMed ID: 28382787
[TBL] [Abstract][Full Text] [Related]
17. 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.
Rider LG; Aggarwal R; Pistorio A; Bayat N; Erman B; Feldman BM; Huber AM; Cimaz R; Cuttica RJ; de Oliveira SK; Lindsley CB; Pilkington CA; Punaro M; Ravelli A; Reed AM; Rouster-Stevens K; van Royen-Kerkhof A; Dressler F; Magalhaes CS; Constantin T; Davidson JE; Magnusson B; Russo R; Villa L; Rinaldi M; Rockette H; Lachenbruch PA; Miller FW; Vencovsky J; Ruperto N;
Arthritis Rheumatol; 2017 May; 69(5):911-923. PubMed ID: 28382778
[TBL] [Abstract][Full Text] [Related]
18. Consensus-based recommendations for the management of juvenile dermatomyositis.
Bellutti Enders F; Bader-Meunier B; Baildam E; Constantin T; Dolezalova P; Feldman BM; Lahdenne P; Magnusson B; Nistala K; Ozen S; Pilkington C; Ravelli A; Russo R; Uziel Y; van Brussel M; van der Net J; Vastert S; Wedderburn LR; Wulffraat N; McCann LJ; van Royen-Kerkhof A
Ann Rheum Dis; 2017 Feb; 76(2):329-340. PubMed ID: 27515057
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic Inflammatory Myopathies: an Update on Classification and Treatment with Special Focus on Juvenile Forms.
Pagnini I; Vitale A; Selmi C; Cimaz R; Cantarini L
Clin Rev Allergy Immunol; 2017 Feb; 52(1):34-44. PubMed ID: 26429707
[TBL] [Abstract][Full Text] [Related]
20. Myositis registries and biorepositories: powerful tools to advance clinical, epidemiologic and pathogenic research.
Rider LG; Dankó K; Miller FW
Curr Opin Rheumatol; 2014 Nov; 26(6):724-41. PubMed ID: 25225838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
